Topic: Pfizer Inc.

What is azithromycin?

Azithromycin was discovered by Croatian medical researchers in the 1980s, and the patents were subsequently licensed by Pfizer for use in Europe and the United States. - Dosage and Side Effects - Azithromycin comes in tablet and oral suspension forms for home ...
Positive Antiviral Responses Demonstrated in Interim 16 Week Analysis from SPRING-1 Study Antiviral activity shown by S/GSK1349572 in treatment-experienced subjects resistant to raltegravir from VIKING Study. Shionogi-ViiV Healthcare LLC today reported data from two Phase IIb studies showing that its once-daily, unboosted ...
Federal health advisers said Thursday that Pfizer's HIV drug Selzentry should be approved for use by patients who have not already taken other drugs to combat the virus.The Food and Drug Administration's panel of virus experts voted 10-4 in favor of the ...

Drugmakers to supply cheap HIV treatments

Former US president Bill Clinton announced a deal Thursday with two major US drug companies to supply cheap HIV/AIDS and tuberculosis treatments to developing countries.Under the agreement, Mylan and its subsidiary Matrix will make available a second-line therapy of four antiretroviral drugs ...
Agreements between former President Bill Clinton's foundation and two drug companies will lower prices on medications for patients with drug-resistant HIV in the developing world.One agreement, with Mylan Inc., lowers the annual price of four antiretroviral drugs that are used as a ...

Bill Clinton, drugmakers announce cheaper HIV drugs

NEW YORK (Reuters) - Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.Second-line antiretroviral therapies and a drug used to treat ...

Glaxo And Pfizer Join Forces

British drugmaker GlaxoSmithKline is teaming up with American rival Pfizer to secure a fifth of the market for treatments against the HIV virus, helping to contain Glaxo's falling HIV drug sales and paving the way for similar arrangements in the pharmaceutical sector. ...
Pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. will pool resources to create a new company to develop and sell HIV medicines, leveraging a small investment into the No. 2 market position.The deal, announced Thursday, reflects two trends sweeping the industry. Companies are ...
Creates a new focused HIV business with the independence and sustainability to deliver significant improvements in treatment, access and shareholder value - Renews focus on HIV with industry-leading pipeline to deliver more new HIV treatments - Equity split of 85% GSK and ...
Results from MERIT ES Data Reanalysis Using Enhanced Sensitivity Tropism Test at 48 Weeks. Patients taking Selzentry, in combination with Combivir? (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to ...
Previous
  • 1
  • 2